Document is current
Any future updates will be listed below
-
Authors
Koizumi, Hideki
Honda, Shigeru
Yasukawa, Tsutomu
Kishino, Genichiro
Sekiryu, Tetsuju
Schulze, Andrea
Yamashita, Takuto
Schmidt-Ott, Ursula
Zhao, Min
Zhang, Xin
Berliner, Alyson J.
Chu, Karen W.
Reed, Kimberly
Cheng, Yenchieh
Bhore, Rafia
Vitti, Robert
Fujita, Ikuko
Leal, Sergio
Iida, Tomohiro
,
-
Funding
Funding for this research was provided by:
Bayer AG
Regeneron Pharmaceuticals, Inc.
- License Information
-
More Information
Article History
Received: 28 April 2025
Accepted: 2 July 2025
First Online: 26 December 2025
Declarations
:
: H. Koizumi, Consulting fees (Allergan, Astellas, Bayer, Boehringer Ingelheim, Chugai/Roche, Janssen, Novartis, Otsuka), Financial support (Alcon, AMO, Bayer, Canon, Chugai, First Medical, HOYA, Kowa, Novartis, Nikon, Otsuka, Pfizer, Santen, Senju, Staar Japan, TOMEY), Lecturer (AbbVie, Alcon, AMO, Bayer, Bausch & Lomb, Canon, Chugai/Roche, Kowa, HOYA, Inami, JFC, Nidek, Novartis, Otsuka, Pfizer, Sanofi, Santen, Senju, Sumitomo Dainippon, TOMEY, Topcon); S. Honda, Grants (Chugai, Santen, Senju), Speaker and/or Lecture Fees (Bayer, Chugai, Kowa, Novartis, Santen, Senju); T. Yasukawa, None; G. Kishino, None; T. Sekiryu, None; A. Schulze, Employee (Bayer); T. Yamashita, Employee (Bayer); U. S-Ott, Employee (Bayer); M. Zhao, Employee (Bayer); X. Zhang, Employee (Bayer); A. J. Berliner, Employee (Regeneron);K. W. Chu, Employee (Regeneron); K. Reed, Employee (Regeneron); Y. Cheng, Employee (Regeneron); R. Bhore, Employee (Regeneron); R. Vitti, Employee (Regeneron); I. Fujita, Employees (Bayer), S. Leal, Employee (Bayer); T. Iida, Grants (AMO, HOYA, Alcon, Nidek, Novartis, Santen, Senju, Topcon), Consulting fees (Bayer, Chugai, Janssen, Boehringer Ingelheim, Novartis), Lecture/travel fees (Bayer, Canon, Chugai, Alcon, Kyowa Kirin, Nidek, Nikon, Novartis, Otsuka, Santen, Senju, Topcon).
